• #Patient-Centricity
• #Science and Technology
• #Sustainability

Innovating Pharmaceutical Packaging to Protect Patients and the Planet: Chugai's Challenge to Implement Recycled Plastics and Biomass-Based Materials

Pharmaceutical packaging is far more than a simple container. It serves a vital mission: safeguarding drug quality, supporting improved usability for patients,

• R&D
• Sustainability
• Sustainable Healthcare
• Global Environment

• #Patient-Centricity
• #Science and Technology
• #Co-Creation

"Creating Drugs That Benefit the World": A Century of Purpose and the Future Chugai Is Building

On March 10, 2025, Chugai Pharmaceutical celebrated its 100th anniversary. To commemorate this milestone, we held a Commemorative Ceremony in May 2025,

• Innovation
• Sustainable Healthcare
• 100th Anniversary

• #Patient-Centricity
• #Digital Technology
• #Co-Creation

Carrying Patient Voices Into the Future: Japan’s Bleeding Disorders Registry

Delivering optimal care even for rare diseases — driven by this commitment, patient advocacy groups, an academic society, and a pharmaceutical company

• Disease Awareness
• Sustainable Healthcare

• #Science and Technology
• #Open Innovation

“CHUGAI INNOVATION DAY 2025” Event Report

The business conference "CHUGAI INNOVATION DAY 2025" hosted by Chugai Pharmaceutical was held at Marunouchi Building Hall & Conference Square (Marunouchi,

• Innovation
• R&D
• DX
• Partnering
• Event
• 100th Anniversary

• #Co-Creation

Passing the Baton of Passion: The "My Action Declaration" 100th Anniversary Project

On March 10, 2025, Chugai Pharmaceutical celebrated its 100th anniversary. As part of this historic milestone, the company launched "My Action Declaration," an

• Innovation

• #Business Models
• #Science and Technology
• #Digital Technology

Pharmaceutical Development Accelerated with Real-world data (RWD) - Taking on the Challenge of Developing Acute-phase Therapeutic Drugs in Collaboration with MeDiCU, Inc.

Chugai Pharmaceutical utilizes real-world data (RWD)* for increased efficiency and advancement in the clinical development of new drugs, verification of drug

• R&D
• DX
• External Experts

• #Science and Technology
• #Open Innovation

Creating and Expanding Regulatory T cells: The Possibility of Cellular Therapy Explored by a Joint Research Team from Chugai and the Immunology Frontier Research Center (IFReC), the University of Osaka

The immune system protects the body from harm. In this process, regulatory T cells act as regulators or brakes suppressing excessive immune responses. A recent

• Innovation
• R&D

• #Sustainability
• #Co-Creation

Learning Through Play: Cutting-Edge Drug Discovery at EXPO 2025. Chugai Employees Take On the Challenge of "Designing Future Society for Our Lives" at the Osaka-Kansai World Expo

"I defeated the cancer cells!" "Making medicine seems tough, but it's so cool!" The event venue was bustling with families, and children's excited voices echoed

• Sustainability
• Sustainable Healthcare
• Social Contribution
• Event

• #Digital Technology
• #Open Innovation
• #Co-Creation

CHUGAI INNOVATION DAY 2024 Report—More Than 3,000 in Attendance

Chugai Pharmaceutical’s CHUGAI INNOVATION DAY 2024 was hosted on November 25 (Mon) and 26 (Tue), 2024. This was the fifth hosting of the CHUGAI INNOVATION

• Innovation
• R&D
• DX
• Event

• #Science and Technology

Working to Reform the Drug Discovery Process—Acceleration of Drug Discovery Research Using Cryo-EM

Torizawa is general manager of the Protein Science Research Department. He is currently in charge of the early stages of drug discovery to uncover molecules

• Innovation
• R&D
• Recruitment
• Research
• Cryo-Electron Microscopy

• #Science and Technology
• #Digital Technology

Working Toward Greater Efficiency in the Drug Discovery Process for Macrocyclic Peptides. Development of a Crystallization Confirmation App Using Agile Development Methods

Agile development has recently been garnering attention as a method that involves quickly ascertaining needs and progressing with a project in an agile and

• Innovation
• R&D
• DX
• Macrocyclic Peptide Drugs

• #Science and Technology
• #Digital Technology

Next-generation pharmaceutical lead by digital technology Taking on innovative drug development with a data-driven approach

The Pharmaceutical Technology Division is in charge of the development process leading to the commercialization of candidate molecules. Within that division,

• R&D
• DX
• Recruitment
• Research
• Drug Discovery Modalities
• Production Technology

• #Science and Technology
• #Sustainability
• #Co-Creation

To become a top runner in drug production. Taking on the challenge of innovative drug manufacturing with next-generation manufacturing facilities

Chugai Pharmaceutical’s bio drug substance (DS) manufacturing facility “UK4,” which contributes to the realization of sustainable global

• R&D
• Recruitment
• Sustainability
• Supply Chain Management
• Drug Discovery Modalities

• #Sustainability

Corporate Growth Through Employee Health: Health and Productivity Management Alongside Employees to Create Platforms for Innovation and Working Environments for Peace of Mind

Chugai Pharmaceutical contributes to the health of people across the world through its innovative pharmaceuticals and services. Essential to fulfilling this

• Sustainability
• Human Resources
• Health and Productivity Management

• #Digital Technology
• #Co-Creation

Takao Suzuki was previously an employee at Microsoft where he supported numerous companies as director of the DX strategy advisory department. He now works as Head of the DX Unit at Chugai Pharmaceutical. According to Suzuki, what are the key factors to ensuring the successful implementation of DX?

Aiming to become the top innovator in the healthcare industry, Chugai Pharmaceutical has positioned DX as a fundamental element of its growth strategy. Phase 1

• Innovation
• DX
• CHUGAI DIGITAL VISION 2030
• Top Interview